These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 3237528)

  • 1. [Hepatitis B markers in health service personnel with reference to preventive vaccination].
    Stempień R; Małolepsza E; Jabłkowski M; Bielicka G; Górski T
    Pol Tyg Lek; 1988 Jul; 43(29):942-4. PubMed ID: 3237528
    [No Abstract]   [Full Text] [Related]  

  • 2. [Humoral response in health service personnel after administration of hepatitis B vaccine Gen-H-B-Vax].
    Juszczyk J; Rokossowski H; Krajewska M; Piatek A
    Przegl Epidemiol; 1991; 45(1-2):11-6. PubMed ID: 1839075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathogenesis, diagnosis, prophylaxis, and management of hepatitis B virus infection.
    Cooper B
    Compr Ther; 1989 Jul; 15(7):9-15. PubMed ID: 2527714
    [No Abstract]   [Full Text] [Related]  

  • 4. [Prevalence of serum markers of hepatitis B virus in medical and non-medical personnel in a general hospital].
    Sánchez-Quijano A; Rivera F; Lissen E; Ollero M; Lozano F; García de Pesquera F; Vázquez R; Andreu-Kern F
    Med Clin (Barc); 1984 Jun; 83(1):1-3. PubMed ID: 6482541
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effectiveness and tolerance of genetically engineered vaccines for hepatitis B--a comparative study].
    Schmid K; Strebl H; Heck KJ; Weltle D; Raithel HJ
    Gesundheitswesen; 1992 May; 54(5):219-22. PubMed ID: 1535816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Intracutaneous hepatitis B vaccination].
    van Houte DP; Vroom TM
    Ned Tijdschr Geneeskd; 1985 Jun; 129(26):1237-40. PubMed ID: 4022172
    [No Abstract]   [Full Text] [Related]  

  • 7. [Course of antibody titer following preventive hepatitis B vaccination and a recommendation for renewal following the use of H-B-Vax vaccines].
    Kätzner K; Kalitzky M; Steinhagen-Thiessen E; Gatermann S; Laufs R
    Z Gastroenterol; 1985 Jan; 23(1):18-24. PubMed ID: 2932862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune response to hepatitis B vaccine in the staff of a hemodialysis unit.
    Landa L; Rattoni N; Lehne C; Trujillo J; Landa E
    Arch Invest Med (Mex); 1984; 15(2):133-8. PubMed ID: 6487003
    [No Abstract]   [Full Text] [Related]  

  • 9. [Attitude of high-risk personnel to a hepatitis B vaccination campaign in a general hospital].
    San Miguel G; Ortiz de Diego R; Cabero MJ; Fernández Felgueroso E; Carrasco JL; Lardinois R; Pons Romero F
    Med Clin (Barc); 1988 Mar; 90(9):369-73. PubMed ID: 2969068
    [No Abstract]   [Full Text] [Related]  

  • 10. Immune responses to hepatitis B vaccination in hospital staff.
    Pead PJ
    Biomed Pharmacother; 1986; 40(7):251-3. PubMed ID: 2949784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Seroconversion of hepatitis B markers in exposed health service workers after 1 year].
    Lisowska B
    Przegl Epidemiol; 1989; 43(3):309-14. PubMed ID: 2616806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Preventive hepatitis B vaccination].
    Glathe H; Dürkop J; Rasch G
    Z Arztl Fortbild (Jena); 1990; 84(8):381-3. PubMed ID: 2143042
    [No Abstract]   [Full Text] [Related]  

  • 13. [Active preventive vaccination against hepatitis B].
    Jilg W
    Internist (Berl); 1985 Oct; 26(10):633-9. PubMed ID: 2934346
    [No Abstract]   [Full Text] [Related]  

  • 14. [Hepatitis B contamination of Viennese hospital personnel].
    Lorant P; Knapp E; Hofmann H; Frisch-Niggemeyer W; Pichler H
    Wien Klin Wochenschr; 1983 Apr; 95(7):235-40. PubMed ID: 6880206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hepatitis B vaccination of hospital personnel].
    Stelling T; van Hattum J; de Gast GC
    Ned Tijdschr Geneeskd; 1984 Sep; 128(37):1753-7. PubMed ID: 6435001
    [No Abstract]   [Full Text] [Related]  

  • 16. [Hepatitis B virus markers and evaluation of prevention in hospital personnel].
    Fernández Sánchez S; Muñoz Domínguez F; Camarra Romero A; Fernández Diosdado MS
    Rev Sanid Hig Publica (Madr); 1985; 59(9-10):1125-36. PubMed ID: 3835690
    [No Abstract]   [Full Text] [Related]  

  • 17. [H-B-VAX II hepatitis B vaccine (recombinant) produced at the MSD Research Laboratories. Description of the vaccine].
    Przegl Epidemiol; 1991; 45(1-2):3-10. PubMed ID: 1839076
    [No Abstract]   [Full Text] [Related]  

  • 18. [Serologic markers of hepatitis B in patients at a tuberculosis hospital].
    Asratian AA; Danilina GA; Kozhevnikova LK; Marina-Fedorova RF; Zotova IuO
    Probl Tuberk; 1989; (4):36-8. PubMed ID: 2734262
    [No Abstract]   [Full Text] [Related]  

  • 19. [Passive immunological prevention of hepatitis B in health service personnel].
    Stempień R; Jabłkowski M; Latarska D
    Przegl Epidemiol; 1990; 44(3):161-4. PubMed ID: 2084798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Immune response to the vaccine (Hepavax B) against the B virus].
    Pérez V; Fay O
    Acta Gastroenterol Latinoam; 1983; 13(4):675-82. PubMed ID: 6680259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.